Bronzi G, Orlando D, De Feudis L, Delle Monache G, Scudieri M, Sergiacomo L, Bernardi M, Pesa O
Divisione di Medicina Interna, Ospedale S. Massimo, Penne, Pescara.
Minerva Med. 1990 Sep;81(9):591-6.
Hyponatremia complicates ascitic hepatic cirrhosis with frequency and gravity related to the gravity of the cirrhosis itself. When hyponatremia develops, it worsens the already present secondary hyperaldosteronism and makes therapy with spironolactone inefficacious. From a pathophysiologic viewpoint a pathogenetic role in determining hyponatremia is attributable to the reduced plasmatic renal perfusion; in several patients a syndrome of inappropriate ADH secretion develops. Other neurohormonal systems (catecholamines, prostaglandins, natriuretic hormones) are probably very important in modifying renal hemodynamics and renal tubular function. In some patients a causative role for hyponatremia is attributable to iatrogenic factors (e.g.: diuretics). From a therapeutic viewpoint, we examine some schedules, pharmacologic or not, that, however, are far from being useful for all patients. We discuss, mainly, water restriction, osmotic diuretics with or without loop diuretics, loop diuretics followed by sodium reintegration and concentration-reinfusion of ascites or application of peritoneovenous shunt.
低钠血症使腹水型肝硬化病情复杂化,其发生频率和严重程度与肝硬化本身的严重程度相关。当出现低钠血症时,会加重已存在的继发性醛固酮增多症,并使螺内酯治疗无效。从病理生理学角度来看,血浆肾灌注减少在低钠血症的发生中起致病作用;在一些患者中会出现抗利尿激素分泌不当综合征。其他神经激素系统(儿茶酚胺、前列腺素、利钠激素)可能在改变肾血流动力学和肾小管功能方面非常重要。在一些患者中,低钠血症的致病作用可归因于医源性因素(如:利尿剂)。从治疗角度来看,我们研究了一些治疗方案,无论是否为药物治疗,但这些方案远非对所有患者都有用。我们主要讨论限水、联合或不联合襻利尿剂使用的渗透性利尿剂、襻利尿剂后补钠及腹水浓缩回输或应用腹腔静脉分流术。